Early Product Development

With you from all angles of translational development.

Our Early Product Development team brings together global strength and human care. Through Phase IIa, we can provide data-supported solutions nimble enough to fit your scientific and regulatory needs.

We can help with: 

  • Dedicated clinical operations teams with deep understanding of all aspects of early clinical activity and site management (safety, labs, monitoring, technical training, cohort review, and recruitment screening)
  • Operational flexibility for uniquely customized solutions like multi-stage dose escalation protocols and adaptive designs
  • Integrated planning and management to take programs from IND through Proof-of-Concept under a single contract
  • Unique clinical SOPs that cover clinical operations, project management, clinical monitoring, feasibility, start-up, and a Phase I-II site network
  • Therapeutically-aligned teams focused on oncology, CNS, respiratory/autoimmune, hepatic and renal failure, and pediatrics
  • More than 90 dedicated global employees executing studies in North America, Europe, and Asia-Pacific

Real-world evidence for more efficent, patient-focused trials

View Now

Innovating for the future of drug development

View Now

The science of ethnobridging

View Now

Decentralized Clinical Trials and Patient Needs

Watch Now

EPCU Infographic

View Now

We are always available for a conversation.

Submitting...

Communication Preference

Communication Preference